A clinical approach to the use of methotrexate for sarcoidosis.
作者信息
Baughman R P, Lower E E
机构信息
Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio 45267-0564, USA.
出版信息
Thorax. 1999 Aug;54(8):742-6. doi: 10.1136/thx.54.8.742.
Abstract
摘要
相似文献
1
A clinical approach to the use of methotrexate for sarcoidosis.甲氨蝶呤用于结节病的临床应用方法
Thorax. 1999 Aug;54(8):742-6. doi: 10.1136/thx.54.8.742.
2
Neurological picture. Vertebral sarcoidosis mimicking metastases.神经影像学表现。酷似转移瘤的脊椎结节病。
J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):188. doi: 10.1136/jnnp.2009.204636. Epub 2010 Jun 22.
3
Tattoo-Associated Sarcoidosis.纹身相关的结节病
Am J Med. 2020 Dec;133(12):1416-1417. doi: 10.1016/j.amjmed.2020.04.027. Epub 2020 May 20.
4
Medical therapy of sarcoidosis.结节病的医学治疗。
Semin Respir Crit Care Med. 2014 Jun;35(3):391-406. doi: 10.1055/s-0034-1376401. Epub 2014 Jul 9.
5
Clinical images: Radiographic healing of osseous sarcoidosis.临床影像：骨结节病的影像学愈合
Arthritis Rheum. 2005 Jul;52(7):2225. doi: 10.1002/art.21102.
6
Methotrexate for sarcoidosis.用于结节病的甲氨蝶呤。
Sarcoidosis Vasc Diffuse Lung Dis. 1998 Sep;15(2):147-9.
7
Longterm remission of more than 5 years in a patient with progressive multifocal leucoencephalopathy and sarcoidosis.一名进行性多灶性白质脑病合并结节病患者实现了超过5年的长期缓解。
Clin Neurol Neurosurg. 2012 Sep;114(7):1057-8. doi: 10.1016/j.clineuro.2012.02.001. Epub 2012 Mar 3.
8
Cutaneous manifestation of a systemic disease.
Am Fam Physician. 2004 Jan 1;69(1):145-6.
9
Methotrexate in resistant ENL.甲氨蝶呤用于难治性结节性红斑狼疮。
Int J Lepr Other Mycobact Dis. 2004 Dec;72(4):480-2. doi: 10.1489/1544-581X(2004)72<480:MIRE>2.0.CO;2.
10
Use of methotrexate in patients with sarcoidosis.类肉瘤病患者中使用甲氨蝶呤。
Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S183-5. Epub 2010 Oct 28.
引用本文的文献
1
The Gray Area of Sarcoidosis and Tuberculosis: A Diagnostic Enigma.结节病与结核病的灰色地带：一个诊断难题。
Cureus. 2024 Oct 18;16(10):e71763. doi: 10.7759/cureus.71763. eCollection 2024 Oct.
2
Sarcoidosis: A Review of the Guidelines and What's To Come.结节病：指南回顾及未来展望。
Mo Med. 2024 Sep-Oct;121(5):373-378.
3
Cardiac sarcoidosis treated with nonsteroidal immunosuppressive therapy.采用非甾体免疫抑制疗法治疗的心脏结节病。
Int J Cardiol Heart Vasc. 2024 Jul 23;53:101473. doi: 10.1016/j.ijcha.2024.101473. eCollection 2024 Aug.
4
D. Geraint James Lecture: The sarcoidosis saga: what insights from the past will guide us in the future.D. 杰兰特·詹姆斯讲座：结节病传奇：过去的哪些见解将在未来指引我们。
Sarcoidosis Vasc Diffuse Lung Dis. 2023 Dec 20;40(4):e2023057. doi: 10.36141/svdld.v40i4.15282.
5
Sarcoidosis-Related Uveitis: A Review.结节病相关性葡萄膜炎综述
J Clin Med. 2023 Apr 29;12(9):3194. doi: 10.3390/jcm12093194.
6
Graphitic Carbon Nitride Nanoheterostructures as Novel Platforms for the Electrochemical Sensing of the Chemotherapeutic and Immunomodulator Agent MTX.石墨相氮化碳纳米杂化结构作为电化学检测化疗和免疫调节剂 MTX 的新型平台。
Biosensors (Basel). 2022 Dec 29;13(1):51. doi: 10.3390/bios13010051.
7
Sarcoidosis and Its Dermatological Manifestations: A Narrative Review.结节病及其皮肤表现：一篇叙述性综述。
Cureus. 2022 Aug 16;14(8):e28053. doi: 10.7759/cureus.28053. eCollection 2022 Aug.
8
The Long-Term Use of Methotrexate Monotherapy as a Steroid-Sparing Agent for Patients With Pulmonary Sarcoidosis.甲氨蝶呤单药长期用于结节病患者作为类固醇减量剂的研究
Cureus. 2021 Aug 27;13(8):e17509. doi: 10.7759/cureus.17509. eCollection 2021 Aug.
9
Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be.非特发性肺纤维化间质性肺疾病的管理进展：我们目前的状况及未来期望达到的目标
J Clin Med. 2021 Mar 23;10(6):1330. doi: 10.3390/jcm10061330.
10
Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective 'target trial' emulated with Swedish real-world data.与硫唑嘌呤相比，接受甲氨蝶呤治疗的类肉瘤病患者的感染风险：一项使用瑞典真实世界数据进行回顾性“目标试验”模拟研究。
Respirology. 2021 May;26(5):452-460. doi: 10.1111/resp.14001. Epub 2021 Jan 4.
本文引用的文献
1
Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation.英格兰胸内结节病的预后。对136例患者进行五年观察后的回顾。
Br Med J. 1961 Nov 4;2(5261):1165-72. doi: 10.1136/bmj.2.5261.1165.
2
MANIFESTATIONS OF SARCOIDOSIS. ANALYSIS OF 145 PATIENTS, WITH A REVIEW OF NINE SERIES SELECTED FROM THE LITERATURE.结节病的表现。对145例患者的分析，并回顾从文献中选取的九个系列研究。
Am J Med. 1963 Jul;35:67-89. doi: 10.1016/0002-9343(63)90165-7.
3
The late follow-up of chronic sarcoid patients previously treated with corticosteroids.对先前接受过皮质类固醇治疗的慢性结节病患者的晚期随访。
Sarcoidosis Vasc Diffuse Lung Dis. 1998 Mar;15(1):52-8.
4
Steroid-sparing alternative treatments for sarcoidosis.
Clin Chest Med. 1997 Dec;18(4):853-64. doi: 10.1016/s0272-5231(05)70423-8.
5
Predicting respiratory failure in sarcoidosis patients.预测结节病患者的呼吸衰竭
Sarcoidosis Vasc Diffuse Lung Dis. 1997 Sep;14(2):154-8.
6
Alternatives to corticosteroids in the treatment of sarcoidosis.
Sarcoidosis Vasc Diffuse Lung Dis. 1997 Sep;14(2):121-30.
7
Diagnosis and management of neurological sarcoidosis.神经结节病的诊断与管理
Arch Intern Med. 1997 Sep 8;157(16):1864-8.
8
Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy.结节病的预后。复发与皮质类固醇治疗的关系。
Chest. 1997 Mar;111(3):623-31. doi: 10.1378/chest.111.3.623.
9
Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders.用于肺部疾病的免疫抑制和细胞毒性药物治疗。
Am J Respir Crit Care Med. 1997 Feb;155(2):395-420. doi: 10.1164/ajrccm.155.2.9032171.
10
Low-dose methotrexate therapy for childhood sarcoidosis.
J Pediatr. 1997 Jan;130(1):25-9. doi: 10.1016/s0022-3476(97)70306-8.
Zotero 插件